Cabergoline and Exemestane Interaction
Cabergoline and Exemestane have a synergistic interaction with 65% confidence. Exemestane supports hormonal recovery from suppression caused by Cabergoline. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.
Compound Profiles
Cabergoline
Dopamine Agonist | Prolactin Management
Cabergoline exerts its effects by acting as a potent agonist at dopamine D2 receptors on lactotroph cells in the anterior pituitary gland. Prolactin secretion is tonically inhibited by hypothalamic dopamine acting on these D2 receptors, and cabergoline mimics this inhibitory signal with high affinity and prolonged duration.
View full profileExemestane
Steroidal Aromatase Inhibitor | Irreversible Estrogen Control
Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Cabergoline with Exemestane?
Yes, Cabergoline and Exemestane can generally be taken together. Exemestane supports hormonal recovery from suppression caused by Cabergoline. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life.
Is Cabergoline and Exemestane safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: pct agent. Monitor accordingly.
What are the interactions between Cabergoline and Exemestane?
Exemestane supports hormonal recovery from suppression caused by Cabergoline. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. This assessment has 65% confidence and is inferred from pharmacological mechanism analysis.
How should I time Cabergoline and Exemestane?
Cabergoline has a half-life of ~63-69 hours and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.